Association Between Cytochrome 1B1*3 Polymorphism and the Breast Cancer in a Group of Iranian Women

Background As a hormone-dependent cancer, estrogen is involved in the development of breast cancer. CYP1B1 belongs to the P450 superfamily of enzymes and is involved in the metabolism of estrogen. The present study investigates the relationship between CYP1B1*3 rs1056836 polymorphism and breast cancer in Iranian women. Methods The present case-control study was conducted on 79 women with breast cancer and 79 healthy women admitted to Shohadaye Tajrish hospital in Tehran. Blood samples were taken from all the participants and their leukocyte DNA was extracted. The PCR-RFLP method was used for genotyping the participants based on the size of the pieces on the gel. Based on Hardy-Weinberg equilibrium model, the frequency of alleles was calculated. Results The mean age of participants was 48 ± 8 years old in the cancer group and 43±6 years old in the control group. After counting the genotypes, their percentages were calculated as 30.38% for the GG genotype, 37.97% for the GC/CG and 31.65% for the CC in the cancer group and as 32.91% for the GG genotype, 53.16% for the GC/CG and 13.93% for the CC in the control group. Based on Hardy-Weinberg equilibrium model, the frequency of the G allele and C allele was 49.37% and 50.63 in the cancer group, and about 59.49% and 40.51% in the control group. A statistically significant difference was observed between the two groups in terms of the CC homozygotes (P = 0.008). Conclusions The results obtained showed possibility of a significant relationship between CYP1B1 rs1056836 polymorphism and the risk of developing breast cancer, and the polymorphism can, therefore, be said to be involved in the development of this condition.